A 5-HT2C receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference
- 7 November 2011
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 505 (1), 10-13
- https://doi.org/10.1016/j.neulet.2011.07.036
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Agomelatine in the Treatment of Major Depressive DisorderCNS Drugs, 2010
- Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders.Current Drug Targets-CNS & Neurological Disorders, 2003
- Serotonin receptors : their key role in drugs to treat schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxietyPharmacology Biochemistry and Behavior, 2002
- Role of serotonin2C receptors in the control of brain dopaminergic functionPharmacology Biochemistry and Behavior, 2002
- Conditioned place preference: what does it add to our preclinical understanding of drug reward?Psychopharmacology, 2000
- Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptorsBrain Research, 2000
- Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared ratsPharmacology Biochemistry and Behavior, 1994
- Evidence that 5-HT2C receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxietyPsychopharmacology, 1994
- Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis.1986